id: limited_pharmacological_treatment_options_to_treatment_engagement_cooccurring_ptsd_sud
name: Limited Pharmacological Treatment Options â†’ Treatment Engagement for Co-occurring
  PTSD and SUD
from_node:
  node_id: limited_pharmacological_treatment_options
  node_name: Limited Pharmacological Treatment Options
to_node:
  node_id: treatment_engagement_cooccurring_ptsd_sud
  node_name: Treatment Engagement for Co-occurring PTSD and SUD
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Current treatment recommendations for co-occurring PTSD and SUD are limited
  to psychosocial therapies only'
- 'Step 2: Lack of pharmacological alternatives reduces treatment options for individuals
  who cannot access or engage with psychosocial therapies'
- 'Step 3: Reduced treatment diversity limits ability to match interventions to individual
  needs, preferences, and circumstances'
- 'Step 4: Limited options result in lower treatment engagement and reduced recovery
  outcomes'
evidence:
  quality_rating: B
  n_studies: 29
  primary_citation: 'Megan Swannell et al. 2025. "Pharmacological treatments for co-occurring
    PTSD and substance use disorders: A systematic review.." *Journal of substance
    use and addiction treatment*. https://doi.org/10.1016/j.josat.2024.109601'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.727993'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: healthcare_setting
  direction: strengthens
  strength: moderate
  description: Veteran-focused healthcare systems may have different pharmacological
    treatment availability than civilian systems
- name: population_diversity
  direction: strengthens
  strength: strong
  description: Research gap in gender diversity and civilian populations limits generalizability
    of pharmacological treatment options
